At a glance: method validation in hematology

About this Infographic

From a workflow perspective, cost considerations continue to shape adoption in smaller units, which has direct implications for daily practice. From a workflow perspective, threshold harmonization is still an open question, as discussed in the accompanying commentary. Contrary to earlier assumptions, digital tooling shortens time-to-decision considerably, pending validation in prospective studies.

According to consensus recommendations, cross-disciplinary review changes the initial assessment in a sizeable minority of cases, which has direct implications for daily practice. Longitudinal data show that variability between operators remains a key limitation, although confirmatory data are still limited. Across multiple cohorts, digital tooling shortens time-to-decision considerably, which has direct implications for daily practice. Recent studies suggest that pre-analytical factors account for a large share of observed variance, as discussed in the accompanying commentary.

From a workflow perspective, digital tooling shortens time-to-decision considerably, pending validation in prospective studies. In multidisciplinary settings, digital tooling shortens time-to-decision considerably, particularly in resource-constrained settings. In routine practice, threshold harmonization is still an open question, and this trend is expected to continue. Longitudinal data show that patient selection criteria deserve closer scrutiny, pending validation in prospective studies.

Longitudinal data show that cross-disciplinary review changes the initial assessment in a sizeable minority of cases, which has direct implications for daily practice. Recent studies suggest that real-world registries complement randomized trial evidence, particularly in resource-constrained settings. According to consensus recommendations, training and accreditation are decisive for reproducibility, a finding echoed by several independent groups.

When protocols are compared, real-world registries complement randomized trial evidence, and this trend is expected to continue. In multidisciplinary settings, integrating quantitative measures reduces subjective bias, and this trend is expected to continue. From a workflow perspective, real-world registries complement randomized trial evidence, as discussed in the accompanying commentary.

Longitudinal data show that digital tooling shortens time-to-decision considerably, and this trend is expected to continue. According to consensus recommendations, patient selection criteria deserve closer scrutiny, as discussed in the accompanying commentary. In multidisciplinary settings, integrating quantitative measures reduces subjective bias, as discussed in the accompanying commentary. When protocols are compared, cost considerations continue to shape adoption in smaller units, with meaningful differences between subgroups. When protocols are compared, real-world registries complement randomized trial evidence, pending validation in prospective studies.